These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 9009243

  • 1. Synthesis, structure and biological properties of Z-17alpha-(2-iodovinyl)-11beta-chloromethyl estradiol-17beta (Z-CMIV), a high affinity ligand for the characterization of estrogen receptor-positive tumors.
    Quivy J, Leclercq G, Deblaton M, Henrot P, Velings N, Norberg B, Evrard G, Zeicher M.
    J Steroid Biochem Mol Biol; 1996 Sep; 59(1):103-17. PubMed ID: 9009243
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and biological properties of 7alpha-cyano derivatives of the (17alpha,20E/Z)-[125I]iodovinyl- and 16alpha-[125I]iodo-estradiols.
    Ali H, Rousseau J, Paquette B, Dubé C, Marko B, van Lier JE.
    Steroids; 2003 Dec; 68(14):1189-200. PubMed ID: 14643881
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and evaluation of 11beta-substituted 21-chloro/iodo-(17alpha,20E/Z)-19-norpregna-1,3,5(10),20-te traene-3, 17beta-diols: high-affinity ligands for the estrogen receptor.
    Hanson RN, Napolitano E, Fiaschi R.
    J Med Chem; 1998 Nov 19; 41(24):4686-92. PubMed ID: 9822539
    [Abstract] [Full Text] [Related]

  • 4. The stereoisomers of 17alpha-[123I]iodovinyloestradiol and its 11beta-methoxy derivative evaluated for their oestrogen receptor binding in human MCF-7 cells and rat uterus, and their distribution in immature rats.
    Rijks LJ, Boer GJ, Endert E, de Bruin K, van den Bos JC, van Doremalen PA, Schoonen WG, Janssen AG, van Royen EA.
    Eur J Nucl Med; 1996 Mar 19; 23(3):295-307. PubMed ID: 8599961
    [Abstract] [Full Text] [Related]

  • 5. 3,3'4,4'-Tetrachlorobiphenyl exhibits antiestrogenic and antitumorigenic activity in the rodent uterus and mammary cells and in human breast cancer cells.
    Ramamoorthy K, Gupta MS, Sun G, McDougal A, Safe SH.
    Carcinogenesis; 1999 Jan 19; 20(1):115-23. PubMed ID: 9934858
    [Abstract] [Full Text] [Related]

  • 6. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells.
    Steinmetz R, Young PC, Caperell-Grant A, Gize EA, Madhukar BV, Ben-Jonathan N, Bigsby RM.
    Cancer Res; 1996 Dec 01; 56(23):5403-9. PubMed ID: 8968093
    [Abstract] [Full Text] [Related]

  • 7. Naringenin: a weakly estrogenic bioflavonoid that exhibits antiestrogenic activity.
    Ruh MF, Zacharewski T, Connor K, Howell J, Chen I, Safe S.
    Biochem Pharmacol; 1995 Oct 26; 50(9):1485-93. PubMed ID: 7503800
    [Abstract] [Full Text] [Related]

  • 8. Radioimaging of human breast carcinoma xenografts in mice by [123I]-labeled Z-17 alpha-iodovinyl-11 beta-chloromethyl-estradiol.
    Zeicher M, Delcorde A, Quivy J, Dupuis Y, Vervist A, Frühling J.
    Nucl Med Biol; 1996 Jan 26; 23(1):69-73. PubMed ID: 9004917
    [Abstract] [Full Text] [Related]

  • 9. The effect of ICI 164384 and beta-interferon on the growth and steroid receptor profile of breast cancer cell lines.
    Coradini D, Biffi A, Pirronello E, Di Fronzo G.
    Anticancer Res; 1995 Jan 26; 15(6B):2557-61. PubMed ID: 8669823
    [Abstract] [Full Text] [Related]

  • 10. Estrogenic effects of 7alpha-methyl-17alpha-ethynylestradiol: a newly discovered tibolone metabolite.
    Bodine PV, Harris HA, Lyttle CR, Komm BS.
    Steroids; 2002 Jul 26; 67(8):681-6. PubMed ID: 12117614
    [Abstract] [Full Text] [Related]

  • 11. Additive estrogenic activities of a binary mixture of 2',4',6'-trichloro- and 2',3',4',5'-tetrachloro-4-biphenylol.
    Ramamoorthy K, Vyhlidal C, Wang F, Chen I, Safe S, McDonnell DP, Leonard LS, Gaido KW.
    Toxicol Appl Pharmacol; 1997 Nov 26; 147(1):93-100. PubMed ID: 9356311
    [Abstract] [Full Text] [Related]

  • 12. Influence of blockers for the estrogen receptor (ER) and type 1 IGF-receptor on the levels of ER, ER mRNA and IGF-I mRNA in the rat uterus.
    Sahlin L, Eriksson H.
    J Steroid Biochem Mol Biol; 1996 Jul 26; 58(4):359-65. PubMed ID: 8903419
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
    Pink JJ, Jordan VC.
    Cancer Res; 1996 May 15; 56(10):2321-30. PubMed ID: 8625307
    [Abstract] [Full Text] [Related]

  • 17. Synthesis, estrogen receptor binding, and tissue distribution of a new iodovinylestradiol derivative (17alpha,20E)-21-[123I]Iodo-11beta-nitrato-19-norp regna-1,3,5 (10),20-tetraene-3,17-diol (E-[123I]NIVE).
    Rijks LJ, van den Bos JC, van Doremalen PA, Boer GJ, de Bruin K, Doornbos T, Vekemans JA, Posthumus MA, Janssen AG, van Royen EA.
    Nucl Med Biol; 1998 May 15; 25(4):411-21. PubMed ID: 9639304
    [Abstract] [Full Text] [Related]

  • 18. Impact of estradiol structural modifications (18-methyl and/or 17-hydroxy inversion of configuration) on the in vitro and in vivo estrogenic activity.
    Ayan D, Roy J, Maltais R, Poirier D.
    J Steroid Biochem Mol Biol; 2011 Nov 15; 127(3-5):324-30. PubMed ID: 21827856
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and evaluation of B-, C-, and D-ring-substituted estradiol carboxylic acid esters as locally active estrogens.
    Labaree DC, Zhang JX, Harris HA, O'Connor C, Reynolds TY, Hochberg RB.
    J Med Chem; 2003 May 08; 46(10):1886-904. PubMed ID: 12723952
    [Abstract] [Full Text] [Related]

  • 20. Estrogenic activity of a dieldrin/toxaphene mixture in the mouse uterus, MCF-7 human breast cancer cells, and yeast-based estrogen receptor assays: no apparent synergism.
    Ramamoorthy K, Wang F, Chen IC, Norris JD, McDonnell DP, Leonard LS, Gaido KW, Bocchinfuso WP, Korach KS, Safe S.
    Endocrinology; 1997 Apr 08; 138(4):1520-7. PubMed ID: 9075711
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.